"Primary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION.
| Descriptor ID |
D011322
|
| MeSH Number(s) |
N02.421.726.758 N06.850.780.680
|
| Concept/Terms |
Primary Prevention- Primary Prevention
- Disease Prevention, Primary
- Disease Preventions, Primary
- Primary Disease Prevention
- Primary Disease Preventions
- Prevention, Primary
Primordial Prevention- Primordial Prevention
- Preventions, Primordial
- Primordial Preventions
- Prevention, Primordial
|
Below are MeSH descriptors whose meaning is more general than "Primary Prevention".
Below are MeSH descriptors whose meaning is more specific than "Primary Prevention".
This graph shows the total number of publications written about "Primary Prevention" by people in this website by year, and whether "Primary Prevention" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Primary Prevention" by people in Profiles.
-
Aspirin for the Primary Prevention of Cardiovascular Disease: A Review of the Literature and Considerations for Clinical Practice. Cardiol Rev. 2020 Mar/Apr; 28(2):98-106.
-
Impact of Implantable Cardioverter-Defibrillator Interventions on All-Cause Mortality in Heart Failure Patients: A Meta-Analysis. Cardiol Rev. 2019 May/Jun; 27(3):160-166.
-
Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):383-390.
-
Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Electrophysiol. 2017 Jun; 28(6):659-665.
-
The Value of Prevention Research Centers: Breaking New Ground in Prevention Research. Am J Prev Med. 2017 03; 52(3 Suppl 3):S214-S215.
-
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting. Circulation. 2017 May 30; 135(22):2091-2101.
-
A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study. J Am Coll Cardiol. 2016 08 30; 68(9):881-91.
-
The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients. J Neurosurg Pediatr. 2015 Sep; 16(3):329-34.
-
A standardized protocol to reduce pediatric spine surgery infection: a quality improvement initiative. J Neurosurg Pediatr. 2014 Sep; 14(3):259-65.
-
Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e101-14.